Strides Pharma Science Ltd. Share Price Target from 2025 to 2050
Strides Pharma Science Ltd. is a fast-growing Indian pharmaceutical company with a strong presence in regulated markets like the US, Australia, Europe, and emerging economies. Known for its agile manufacturing capabilities and focus on generics, Strides has steadily expanded its global footprint and product portfolio. Backed by robust R&D and strategic acquisitions, the company is well-positioned to tap into the growing demand for affordable healthcare. In this post, we delve into the Strides Pharma Share Price Target & Forecast from 2025 to 2050, examining its core business strengths, financial health, long-term drivers, and expert market sentiment.
Strides Pharma Science Ltd. Overview: Growth, Products, & Market Presence
Strides Pharma Science is a globally operating pharmaceutical company focused on manufacturing and exporting a wide range of generic formulations, including tablets, capsules, ointments, and soft gels. It has manufacturing facilities approved by USFDA, MHRA, TGA, and other global regulators. The company has a strong focus on regulated markets and operates across both prescription and over-the-counter (OTC) categories.
| Details | Information |
|---|---|
| Founded | 1990 |
| Headquarters | Bengaluru, Karnataka, India |
| Sector | Pharmaceuticals |
| Key Segments | Generic Drugs, OTC, Anti-retroviral Therapy, Soft Gels |
| Stock Listings | NSE: STAR, BSE: 532531 |
| Market Presence | USA, Australia, UK, Africa, India, and emerging markets |
On this page, you will find detailed insights into Strides Pharma Science Ltd.’s stock, including real-time prices, technical analysis, and long-term forecasts:
✅ Real-Time Stock Price: Automatically updated every minute for the latest market data.
✅ Technical Indicators: Adjusted based on specific time frames to provide timely trading insights.
✅ Financial Reports: Updated quarterly to reflect the company’s latest financial performance.
✅ Stock Charts: Refreshed every minute for real-time visual analysis.
📊 Note: Strides Pharma Science Ltd.’s stock forecast prices in the tables are automatically updated based on live asset price changes.
Strides Pharma Science Ltd. Financial Overview & Key Metrics
Strides has seen steady growth in revenue driven by new product launches in the US and emerging market expansion. However, profitability has been impacted intermittently by pricing pressures in the US and regulatory costs. The company is actively working on cost optimization and improving its product mix to achieve better margins. Its investment in R&D and partnerships supports a healthy pipeline of products across multiple therapeutic areas.
Below is a detailed breakdown of its key financial figures; including revenue, net profit, earnings per share (EPS), and other crucial metrics. These insights help investors gauge the company’s financial health and long-term growth potential.
Use the landscape mode for best viewing on mobile devices.
Investment Potential & Associated Risks
Why Consider Investing in Strides Pharma Ltd.?
- Strong Global Reach: Operations in over 100 countries provide revenue stability and diversification.
- Focus on the US Market: Significant ANDA filings and product approvals from the USFDA open up large revenue streams.
- Specialty Formulations: Strength in soft gelatin capsules, injectables, and anti-retroviral drugs enhances its niche advantage.
- Strategic Acquisitions: Acquisitions in regulated markets have helped scale quickly and build product pipelines.
- Regulatory Compliance: Most manufacturing plants are globally approved, reducing barriers for new launches.
Risks to Consider
- High R&D Costs: Investments in research and regulatory filings may take time to yield commercial results.
- US Pricing Pressure: Intense competition and pricing erosion in the US generics market can impact margins.
- Regulatory Risks: FDA inspections and potential warnings can delay launches or affect credibility.
- Currency Volatility: With major revenue from exports, forex fluctuations may impact earnings.
Strides Pharma Science Share Price Target: Tomorrow & Weekly Outlook
Strides Pharma Science stock price forecasts for tomorrow and the upcoming week are based on recent market trends, historical price movements, and key technical indicators. These projections offer valuable insights into potential price changes, helping traders and investors make informed decisions.
However, various factors can influence stock prices; including market sentiment, news updates, and global events; so staying updated and flexible with strategies is always wise.
📊 Below, you’ll find the expected stock price targets for the coming days:
| Date | Min. Price | Max. Price | Stock Price |
|---|---|---|---|
| 19-Sep | 876.10 | 904.10 | 889.79 |
| 22-Sep | 889.28 | 917.29 | 901.97 |
| 23-Sep | 878.38 | 906.75 | 892.38 |
| 24-Sep | 874.36 | 904.19 | 888.98 |
| 25-Sep | 876.89 | 905.82 | 891.00 |
| 26-Sep | 880.02 | 908.69 | 893.82 |
| 29-Sep | 890.85 | 920.69 | 905.99 |
| 30-Sep | 882.49 | 911.52 | 896.41 |
| 01-Oct | 877.88 | 908.83 | 893.01 |
Technical Analysis of Strides Pharma Science Ltd. Using Key Indicators
For Strides Pharma Science Ltd., you can leverage indicator-based technical analysis to identify optimal market entry and exit points. Adjust the time frame according to your trading strategy for more accurate insights.
How to Interpret Technical Analysis Signals:
| ✅ Sell” or “Strong Sell | Indicates bearish (negative) market sentiment, suggesting a potential decline. |
| ✅ Buy” or “Strong Buy | Indicates bullish (positive) market sentiment, signaling a potential uptrend. |
Time Frame Considerations:
- Short-Term Analysis (Intraday/Short Swing Trading): Use time frames ranging from 15 minutes to 2 hours.
- Medium to Long-Term Analysis: If you plan to hold for more than a week, use daily to weekly time frames.
Below, you’ll find technical indicator-based buy and sell signals based on different time frames to assist in your investment decisions.
Future Growth Drivers for Strides Pharma Science Ltd.
- New Product Launches in the US: The US remains the biggest revenue contributor, with a solid pipeline of ANDAs for high-margin products.
- Expanding in Emerging Markets: Growing healthcare demand in Africa, South America, and Asia presents a significant opportunity.
- Growth in Soft Gel Segment: The company is among the few players with a global soft gel manufacturing capability, giving it a competitive edge.
- OTC Portfolio Expansion: Diversifying into consumer healthcare and OTC formulations provides volume growth and margin stability.
- Digital Healthcare Push: Strides is investing in digital platforms to enhance reach and distribution, especially in developing economies.
What Will Drive Strides Pharma Science’ Share Price Over the Coming Decades?
The share price performance of Strides Pharma in the coming decades will hinge on its ability to scale up in high-margin markets like the US and maintain compliance with global regulatory standards. As the world continues to demand affordable generics and quality healthcare, Strides’ expansive portfolio and manufacturing base position it for consistent long-term growth. Strategic launches, operational efficiencies, and strong management execution will be the key catalysts for stock performance over time.
Strides Pharma Science Share Price Target & Forecast (2025-2050)
This long-term stock price forecast for Strides Pharma Science Ltd. is based on historical market trends, the company’s growth prospects, and industry analysis. While forecasting stock prices for the long term involves uncertainty, these forecasts help investors gain an understanding of potential future price moves.
📊 The following table presents the Strides Pharma Science share price target forecast from 2025 to 2050, based on current market trends and available data.
| Year | Min. Price | Max. Price |
|---|---|---|
| 2025 | ₹ 884.58 | ₹ 954.55 |
| 2026 | ₹ 881.01 | ₹ 1,090.06 |
| 2027 | ₹ 1,015.74 | ₹ 1,225.32 |
| 2028 | ₹ 1,150.30 | ₹ 1,360.51 |
| 2029 | ₹ 1,285.02 | ₹ 1,494.91 |
| 2030 | ₹ 1,419.91 | ₹ 1,568.56 |
| 2031 | ₹ 1,549.69 | ₹ 1,740.14 |
| 2032 | ₹ 1,677.41 | ₹ 1,880.15 |
| 2033 | ₹ 1,804.78 | ₹ 2,019.78 |
| 2034 | ₹ 1,932.15 | ₹ 2,159.41 |
| 2035 | ₹ 2,059.52 | ₹ 2,299.03 |
| 2040 | ₹ 2,697.08 | ₹ 2,997.94 |
| 2050 | ₹ 3,971.49 | ₹ 4,395.00 |
The Strides Pharma Science Ltd. share price targets provided here are for informational purposes only. Both short-term and long-term stock price predictions are based on historical data and market trends, but actual prices may vary due to market fluctuations and external factors. This forecast assumes positive market conditions and does not account for unforeseen risks, economic uncertainties, or company-specific challenges. Investors should conduct their research before making any financial decisions.
Strides Pharma Science Share Price Target Year-wise Breakdown (2025 to 2050)
Strides Pharma Science Share Price Target 2025
oops, no data
Strides Pharma Science Share Price Target 2026
oops, no data
Strides Pharma Science Share Price Target 2027
oops, no data
Strides Pharma Science Share Price Target 2028
oops, no data
Strides Pharma Science Share Price Target 2029
oops, no data
Strides Pharma Science Share Price Target 2030
oops, no data
Strides Pharma Science Share Price Target 2040
oops, no data
Strides Pharma Science Share Price Target 2050
oops, no data
Live Stock Chart & Price Trends – Strides Pharma Science Ltd.
Track Strides Pharma Science Ltd.’s stock performance in real time with our interactive chart below. This live tool provides up-to-the-minute price movements, trading volume, and market trends, helping investors and market watchers stay fully informed. Easily switch between intraday, daily, weekly, or monthly views, and apply a variety of technical indicators to support deeper analysis. Whether you’re actively trading or simply monitoring the market, this chart offers the insights you need to make smart, timely decisions.
🔗 Also Read: Divi’s Laboratories Share Price Target: Future Outlook
Divi’s Laboratories Ltd. is a globally recognized Indian pharmaceutical company known for manufacturing active pharmaceutical ingredients (APIs), intermediates, and custom synthesis of drug compounds. Read more
Expert Opinions & Market Sentiment
Brokerage & Analyst Ratings
- ICICI Direct: “Buy – Valuation remains attractive; strong recovery expected in US revenue.”
- Axis Securities: “Positive – Favorable ANDA approvals pipeline and cost efficiency measures.”
- HDFC Securities: “Add – Long-term opportunity in niche products and emerging markets.”
Investor Sentiment & Market Trends
- Retail Investors: Growing interest due to Strides’ aggressive product launch strategy and global footprint.
- Institutional Holding: Consistent participation from mutual funds and foreign investors, indicating strong belief in the business model.
- Market Mood: Optimistic in the medium-to-long term, especially as regulatory compliance remains strong.
❓FAQs
Is Strides Pharma a good long-term investment?
Yes, the company’s focus on global generics, niche capabilities, and R&D pipeline make it a promising long-term bet in the pharmaceutical space.
What markets does Strides Pharma serve?
Strides operate in major regulated markets like the US, Australia, and UK, as well as emerging markets across Asia and Africa.
Does Strides Pharma pay dividends?
Yes, the company has paid dividends in the past, though payouts may vary depending on profitability.
What are the major risks of investing in Strides Pharma?
Key risks include pricing pressure in the US, regulatory compliance costs, and forex volatility due to its export-driven model.
How does Strides compare with other pharma companies?
Strides has a unique focus on soft gels and niche formulations, giving it a distinct position compared to peers focused only on conventional generics.
Price Prediction Methodology
Our predictions combine expert analysis, technical indicators, and algorithmic models to provide an informed outlook.
📊 Want to know more? Click here to read our full methodology.
